Development of novel supramolecular drug for the treatments of neointimal lesions and aortic aneurysm
Project/Area Number |
16H05422
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Cardiovascular surgery
|
Research Institution | The University of Tokyo |
Principal Investigator |
Miura Yutaka 東京大学, 大学院工学系研究科(工学部), 客員研究員 (40557980)
|
Co-Investigator(Kenkyū-buntansha) |
Cabral Horacio 東京大学, 大学院工学系研究科(工学部), 准教授 (10533911)
小山 博之 東京大学, 医学部附属病院, 登録研究員 (10241994)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,680,000 (Direct Cost: ¥13,600,000、Indirect Cost: ¥4,080,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2016: ¥8,970,000 (Direct Cost: ¥6,900,000、Indirect Cost: ¥2,070,000)
|
Keywords | 超分子化学 / ナノ材料 / 超分子 |
Outline of Final Research Achievements |
This work deals with the development of novel supramolecular drug for the treatments of neointimal lesions and aortic aneurysm in rats. Moreover, to evaluate the potentials in supramolecular drug as an anti-cancer agent, drug-effect tests were performed against a head and neck tumor model. Our findings suggest that the novel supramolecular drug achieves specific delivery of rapamycin to the rat abdominal aortic aneurysm, neointimal lesions, and solid tumor, and might contribute to establishing a drug therapy approach targeting both aortic diseases and malignant cancers.
|
Academic Significance and Societal Importance of the Research Achievements |
現在、血管内膜肥厚や動脈硬化症などの脈管系疾患を根治に至らしめる薬剤で上市されたものは存在しない。そのため、同疾患の治療に於いては、低侵襲かつ継続的な薬物治療が可能な新規治療法の確立が求められていた。本研究では超分子化学の側面から新たに脈管系疾患を対象とした薬剤の開発を行い、血管内膜肥厚ならびに動脈瘤の進行を抑制する成果を得ている。日本における死亡原因の上位は心臓・血管に由来する疾病であり、これに対する革新的な治療戦略の開発は我が国の将来にとって最も重要な基盤研究の一つと位置づけられ、本研究の成果が今後の医療に役立つことが期待されている。
|
Report
(4 results)
Research Products
(31 results)
-
-
-
-
[Journal Article] Proteasome inhibitor loaded micelles enhance antitumor activity through macrophage reprograming by NF-κB inhibition"2017
Author(s)
Hailiang Wu, Anqi Tao, John D. Martin, Sabina Quader, Xueying Liu, Kei Takahashi, Louise Hespel, Yutaka Miura, Yoshihiro Hayakawa, Tatsuro Irimura, Horacio Cabral, Kazunori Kataoka
-
Journal Title
J. Pharm. Sci,
Volume: -
Issue: 9
Pages: 30217-30224
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
[Presentation] Proteasome inhibitor loaded micelles enhance antitumor activity through macrophage reprograming by NF-κB inhibition2017
Author(s)
J. D. Martin, H. Wu, A. Tao, S. Quader, X. Liu, K. Takahashi, L. Hespel, Y. Miura, Y. Hayakawa, T. Irimura, H. Cabral, K. Kataoka
Organizer
11th Annual Symposium on Nanobiotechnology 2017
Place of Presentation
Kawasaki City Industrial Promotion Hall, Kawasaki, Kanagawa
Year and Date
2017-02-27
Related Report
Int'l Joint Research
-
-
[Presentation] Proteasome inhibitor loaded micelles enhance antitumor activity through macrophage reprogramming by NF-kB inhibition2017
Author(s)
J. D. Martin, H. Wu, A. Tao, S. Quader, X. Liu, K. Takahashi, L. Hespel, Y. Miura, Y. Hayakawa, T. Irimura, H. Cabral, K. Kataoka
Organizer
Cancer Nanotechnology Gordon Research Conference Multimodal Nano-Therapies Against Cancer
Related Report
Int'l Joint Research
-
-
-
-
-
[Presentation] Nanomedicine strategies for enhancing efficacy against head and neck squamous cell carcinoma bearing cancer stem-like cells2016
Author(s)
H. Cabral, K. Miyano, M. Wang, Y. Miura, Y. Matsumoto, H. Kinoh, N. Nishiyama, T. Yamasoba, K. Kataoka
Organizer
Frontiers2016 - Joint Symposium of the EPFL and the University of Tokyo
Place of Presentation
Swiss Federal Institute of Technology(EPFL), Lausanne, Switzerland
Year and Date
2016-12-05
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] Brain tumor targeting by cRGD peptide encircled polymeric micelles loaded with potent antiglioblastoma agent epirubicin2016
Author(s)
S. Quader, X. Liu, Y. Chen, P. Mi, T. Chida, T. Ishii, Y. Miura, N. Nishiyama, H. Cabral, K. Kataoka
Organizer
3rd Internatioal Conference on Biomaterials Science in Tokyo(ICBS2016)
Place of Presentation
Ito Hall located at The University of Tokyo, Tokyo, Japan
Year and Date
2016-11-28
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-